The article offers the insights of several experts on the use of stem-cell transplant as tool for myeloma treatment. According to haematologist Michele Cavo, European physicians prefer to postpone transplant until the time of relapse. Medical and scientific director James Berenson, says that stem cell transplants are not worthwhile. It also offers the insights of myeloma patients such as Dennis Dinger and Pat Killingsworth.